[INFOGRAPHIC] OIG's 2013 Work Plan and How It Affects Urology
In this graphic, parts of the Office of the Inspector General 2013 Work Plan that might affect a urology practice are discussed.
As indicated by these numbers, the Department of Health and Human Services’ Office of the Inspector General (OIG) has a broad reach in enforcing the requirements of Medicare and other programs that fall under HHS. Given the high proportion of Medicare beneficiaries in a typical practice, it is likely that more than one urologist has been or will be affected. Below is some of what you need to know about OIG’s relevance to your practice. For more, read the full article - The OIG: What you don’t know can hurt you
Part 1: What you don’t know can hurt you
Look for parts 2 and 3 of this series in the April 1 and May issues of Urology Times:
AUA, SUFU publish 2024 guideline for idiopathic overactive bladder
April 25th 2024“This brand new guideline offers options for all patients with OAB with a focus on shared decision-making between patients with OAB and clinicians, as well as a personalized, tailored approach to care,” said Cameron and Smith.
Enzalutamide granted approval in EU for nmHSPC
April 24th 2024The approval is supported by data from the phase 3 EMBARK trial, which demonstrated that enzalutamide with or without leuprolide prolonged metastasis-free survival compared with leuprolide alone in patients with high-risk biochemically recurrent nmHSPC.
